Special Issue "Milk Nutraceutical Proteins and Peptides in Health and Disease"
Deadline for manuscript submissions: closed (31 March 2021).
2. Interuniversity Consortium Biostructures and Biosystems National Institute (INBB), 00136 Rome, Italy
Interests: molecular mechanisms of metabolic control in eukaryotes and prokaryotes and their biotechnological applications on microbial detection
Special Issues and Collections in MDPI journals
Interests: drug delivery; antibody drug conjugates; toxins; cancer therapy; ribosome inactivating proteins; transferrins
Nutraceuticals (fusion of: “nutrition” and “pharmaceuticals”) are bioactive molecules derived from food, which provide prevention and treatment of diseases. Either small organic molecules or proteins and peptides derived from both animal and vegetal sources may be nutraceuticals, which may be present in conventional food or may be added as nutritional supplements to the diet. Nutraceuticals have recently received considerable interest due to their pharmacological effects and because they are perceived as safe and less likely to have side effects. For these reasons, their market is growing fast around the world.
The purpose of this Special Issue entitled "Milk Nutraceutical Proteins and Peptides in Health and Disease" is to provide new insights and comprehensively review the data from basic and clinical research to discuss the benefits as well as potential side effects of milk proteins and their peptides both in preventing and treating several human pathologies. Topics are focused on nutraceuticals/supplements analysis, intake, absorption and metabolism, cell signaling, gene expression, and difference in cellular effects. The overall goal of this Special Issue is to present readers with high-quality scientific evidence for the use of nutraceuticals as dietary supplements or functional foods that can be properly used to improve physical wellness in health and disease.
Prof. Dr. Giovanni Antonini
Dr. Francesco Giansanti
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Nutraceuticals proteins
- Nutraceutical peptides
- Functional foods
- Nutritional supplements
- in vitro and in vivo studies
- Clinical trials